CHASE AFTER A CURE INC RINGLER (EIN 272227360) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

WHITNEY RINGLER

Phone

8432702954

Tax Period

2017-05-01 to 2018-04-30

CHASE AFTER A CURE INC RINGLER, founded in 2010, is a micro nonprofit in the Medical Research sector that reported $26K in total revenue in fiscal year 2017. Revenue fell 83% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $5K, a strong 19% operating margin.

Mission

CHASE AFTER A CURE IS A NON-PROFIT CORPORATION DEDICATED TO CHILDREN'S CANCER RESEARCH. WE RAISE AWARENESS FOR CHILDREN'S CANCER AND PROVIDE FUNDING FOR RESEARCH LABS WHO SPECIALIZE IN CHILDREN'S CANCER RESEARCH. OUR MAIN FOCUS FOR RESEARCH IS THE MORE AGGRESSIVE AND DEADLY CANCER CALLED NEUROBLASOMA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2017)

Revenue Breakdown

Contributions & Grants $24,082

Program Service Revenue $0

Investment Income $0

Other Revenue $1,956

TOTAL REVENUE $26,038

Expense Breakdown

Grants Paid $0

Salaries & Benefits $14,802

Fundraising Expenses $1,480

Program Expenses $13,831

Other Expenses $6,172

TOTAL EXPENSES $20,974

Year-over-Year Comparison

	2017	2016	Change
Revenue	$26,038	$155,441	-0.8%
Expenses	$20,974	$150,283	-0.9%
Net Income	$5,064	$5,158	0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✓ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✓ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WHITNEY RINGLER	PRESIDENT	N/A	Director	$0	$0	$0
DEBBIE RUPERT	BOARD OF DIR	N/A	Officer	$0	$0	$0
LISA CATES	BOARD OF DIR	N/A	Officer	$0	$0	$0
LORI A MILES CPA	TREASURER	N/A	Officer	$0	$0	$0
JOY DATTA	BOARD OF DIR	N/A	Officer	$0	$0	$0
CHAD SHELTON	BOARD OF DIR	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$26,038	$20,974	$28,782	$5,064

CHASE AFTER A CURE INC RINGLER